Biomimetic matrices for myocardial stabilization and stem cell transplantation

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 4, 2010, Pages 1055-1066

  Wall, Samuel T ^a   Yeh, Che Chung ^b   Tu, Richard Y K ^b   Mann, Michael J ^b,c   Healy, Kevin E ^a,d  

^a University of California at Berkeley   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

myocardial infarct; stem cells; synthetic hydrogels; tissue engineering

Indexed keywords

ADULT MICE; ASSISTIVE; BIOLOGICAL MATRIXES; BIOLOGICAL PROPERTIES; BIOMIMETIC MATRICES; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; CARDIAC INJURIES; CROSS-LINKERS; DONOR CELLS; GREEN FLUORESCENT PROTEIN; IN-VITRO; LV FUNCTION; MATRIGEL; MATRIX; MATRIX METALLOPROTEINASES; MICROENVIRONMENTS; MYOCARDIAL INFARCT; MYOCARDIAL INFARCTION; SALINE INJECTION; SEMI-INTERPENETRATING POLYMER NETWORKS; STEM CELL; STEM CELL TRANSPLANTATION; SYNTHETIC HYDROGELS; SYSTEMATIC OPTIMIZATION; TRANSIENT IMPROVEMENT;

BIOLOGICAL MATERIALS; BIOMIMETICS; CELL CULTURE; ENZYME ACTIVITY; MECHANICAL PROPERTIES; STEM CELLS; TISSUE ENGINEERING;

HYDROGELS;

COLLAGENASE 3; GELATINASE A; GELATINASE B; GREEN FLUORESCENT PROTEIN; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMIMETICS; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART INFARCTION; HISTOLOGY; HYDROGEL; MESENCHYMAL STEM CELL; MICHAELIS MENTEN KINETICS; MOUSE; NONHUMAN; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GREEN FLUORESCENT PROTEINS; HYDROGEL; MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; POLYMERS; TIME FACTORS;

EID: 78449301241     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32904     Document Type: Article

References (49)

1. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P,. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-10349.
2. Hamano K, Li TS, Kobayashi T, Hirata K, Yano M, Kohno M, Matsuzaki M,. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg 2002; 73: 1210-1215.
3. Tomita S, Mickle DAG, Weisel RD, Jia ZC, Tumiati LC, Allidina Y, Liu P, Li RK,. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002; 123: 1132-1140.
4. Kawamoto A, Tkebuchava T, Yamaguchi JI, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T,. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003; 107: 461-468.
5. Mangi AA, Noiseux N, Kong DL, He HM, Rezvani M, Ingwall JS, Dzau VJ,. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-1201.
6. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H,. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomized controlled clinical trial. Lancet 2004; 364: 141-148.
7. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H,. Intracoronary bone marrow cell transfer after myocardial infarction-Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113: 1287-1294.
8. Kang HJ, Kim HS, Koo BK, Kim YJ, Lee D, Sohn DW, Oh BH, Park YB,. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomized clinical trial. Lancet 2004; 363: 751-756.
9. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R,. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001; 37: 1726-1732.
10. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P,. Transplanted Adult Bone Marrow Cells Repair Myocardial Infarcts in Mice. Annals of the New York Academy of Science 2001; 938: 221-230.
11. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P,. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.
12. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marban E,. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007; 115: 896-908.
13. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC,. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005; 112: I173-I177.
14. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD,. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-98.
15. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu CH, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen YH, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE,. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-1024.
16. Christman KL, Fok HH, Sievers RE, Fang QH, Lee RJ,. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 2004; 10: 403-409.
17. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR,. Isolation and characterization of type-IV procollagen, laminin, and heparan-sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982; 21: 6188-6193.
18. Kutschka I, Chen IY, Kofidis T, Arai T, von Degenfeld G, Sheikh AY, Hendry SL, Pearl J, Hoyt G, Sista R, Yang PC, Blau HM, Gambhir SS, Robbins RC,. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006; 114: I167-I173.
19. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J,. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008; 117: 1388-1396.
20. Davis ME, Hsieh PCH, Grodzinsky AJ, Lee RT,. Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005; 97: 8-15.
21. Davis ME, Motion JPM, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, Zhang SG, Lee RT,. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005; 111: 442-450.
22. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM,. Theoretical impact of the injection of material into the myocardium-A finite element model simulation. Circulation 2006; 114: 2627-2635.
23. Dai W, Wold LE, Dow JS, Kloner RA,. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: A novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol 2005; 46: 714-719.
24. Tsur-Gang O, Ruvinov E, Landa N, Holbova R, Feinberg MS, Leor J, Cohen S,. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 2009; 30: 189-195.
25. Yu J, Gu Y, Du K, Mihardja S, Sievers RE, Lee RJ,. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials 2009; 30: 751-756.
26. Wang T, Wu DQ, Jiang XJ, Zhang XZ, Li XY, Zhang JF, Zheng ZB, Zhuo RX, Jiang H, Huang CX,. Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling. Eur J Heart Failure 2009; 11: 14-19.
27. Jiang X, Wang T, Li X, Wu D, Zheng Z, Zhang J, Chen J, Peng B, Jiang H, Huang C, Zhang X,. Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction. J Biomed Mater Res A 2009; 90: 472-477.
28. Fujimoto KL, Ma ZW, Nelson DM, Hashizume R, Guan JJ, Tobita K, Wagner WR,. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 2009; 30: 4357-4368.
29. Stile RA, Healy KE,. Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules 2001; 2: 185-194.
30. Kim S, Healy KE,. Synthesis and characterization of injectable poly(N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. Biomacromolecules 2003; 4: 1214-1223.
31. Kim S, Chung EH, Gilbert M, Healy KE,. Synthetic MMP-13 degradable ECMs based on poly(N-isopropylacrylamide-co-acrylic acid) semi-interpenetrating polymer networks. I. Degradation and cell migration. J Biomed Mater Res A 2005; 75: 73-88.
32. Chung EH, Gilbert M, Virdi AS, Sena K, Sumner DR, Healy KE,. Biomimetic artificial ECMs stimulate bone regeneration. J Biomed Mater Res A 2006; 79: 815-826.
33. Bellahcene A, Bonjean K, Fohr B, Fedarko NS, Robey FA, Young MF, Fisher LW, Castronovo V,. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000; 86: 885-891.
34. Engler A, Bacakova L, Newman C, Hategan A, Griffin M, Discher D,. Substrate compliance versus ligand density in cell on gel responses. Biophys J 2004; 86: 617-628.
35. Engler AJ, Sen S, Sweeney HL, Discher DE,. Matrix elasticity directs stem cell lineage specification. Cell 2006; 126: 677-689.
36. Saha K, Keung AJ, Irwin EF, Li Y, Little L, Schaffer DV, Healy KE,. Substrate modulus directs neural stem cell behavior. Biophys J 2008; 95: 4426-4438.
37. Kamide K,. Thermodynamics of Polymer Solutions. Phase Equilibria and Critical Phenomena. Amsterdam: Elsevier Science Publishers; 1990.
38. Stile RA, Burghardt WR, Healy KE,. Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 1999; 32: 7370-7379.
39. Peterson JT, Li H, Dillon L, Bryant JW,. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 2000; 46: 307-315.
40. Deng SJ, Bickett DM, Mitchell JL, Lambert MH, Blackburn RK, Carter HL, Neugebauer J, Pahel G, Weiner MP, Moss ML,. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library. J Biol Chem 2000; 275: 31422-31427.
41. Huebsch N, Gilbert M, Healy KE,. Analysis of sterilization protocols for peptide-modified hydrogels. J Biomed Mater Res B Appl Biomater 2005; 74: 440-447.
42. Grossman W, Jones D, McLaurin LP,. Wall stress and patterns of hypertrophy in human left-ventricle. J Clin Investig 1975; 56: 56-64.
43. Jackson BM, Gorman JH, Moainie SL, Guy TS, Narula N, Narula J, John-Sutton MG, Edmunds LH, Gorman RC,. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1160-1167.
44. Takernura G, Fujiwara H,. Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 2006; 10: 56-75.
45. Hayakawa K, Takemura G, Kanoh M, Li YW, Koda M, Kawase Y, Maruyama R, Okada H, Minatoguchi S, Fujiwara T, Fujiwara H,. Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 2003; 108: 104-109.
46. Fujimoto KL, Tobita K, Merryman WD, Guan JJ, Momoi N, Stolz DB, Sacks MS, Keller BB, Wagner WR,. An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J Am Coll Cardiol 2007; 49: 2292-2300.
47. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JWU, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SEW, Fleischmann IK,. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362-1369.
48. Mirotsou M, Zhang ZY, Deb A, Zhang LN, Gnecchi M, Noiseux N, Mu H, Pachori A, Dzau V,. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA 2007; 104: 1643-1648.
49. Xu MF, Uemura R, Dai Y, Wang YG, Pasha Z, Ashraf M,. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 2007; 42: 441-448.